Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-25

Clinical Trial Update: C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for C14 in patients with advanced and/or metastatic solid tumors; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C14 (Monoterpenoid Zinc Tetra-ascorbo-camphorate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-25